Empagliflozin potently reduces sarcoplasmic Ca leak and increases Ca transient amplitude of human failing ventricular cardiomyocytes

Mustroph, J. and Wagemann, O. and Trum, M. and Lebek, S. and Tarnowski, D. and Reinders, J. and Schmid, C. and Schopka, S. and Hilker, M. and Graf, B. and Pabel, S. and Sossalla, S. and Schweda, F. and Maier, L. S. and Wagner, S. (2018) Empagliflozin potently reduces sarcoplasmic Ca leak and increases Ca transient amplitude of human failing ventricular cardiomyocytes. EUROPEAN HEART JOURNAL, 39 (Suppl1): 3145. p. 644. ISSN 0195-668X, 1522-9645

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Anästhesiologie
Medicine > Institut für Funktionelle Genomik > Lehrstuhl für Funktionelle Genomik (Prof. Oefner)
Medicine > Lehrstuhl für Herz-, Thorax- und herznahe Gefäßchirurgie
Medicine > Lehrstuhl für Innere Medizin II
Biology, Preclinical Medicine > Institut für Physiologie > Prof. Dr. Frank Schweda
Depositing User: Petra Gürster
Date Deposited: 03 Jul 2020 06:11
Last Modified: 03 Jul 2020 06:11
URI: https://pred.uni-regensburg.de/id/eprint/14087

Actions (login required)

View Item View Item